It's time to phase in<i><scp>RHD</scp></i>genotyping for patients with a serologic weak<scp>D</scp>phenotypeS. Gerald Sandler, Clayton D. Simon, Meghan Delaney et al.|Transfusion|2014Cited by 195
It's time to phase out “serologic weak D phenotype” and resolve D types with <i>RHD</i> genotyping including weak D type 4Willy A. Flegel, S. Gerald Sandler, Gregory A. Denomme et al.|Transfusion|2020Cited by 56